prepare ppt for Cardiology Journal club. Use figures and picture from article

Created using ChatSlide

The presentation titled 'MAPLE-HCM: Aficamten Versus Metoprolol' focuses on a randomised phase 3 trial assessing the efficacy of aficamten in improving exercise capacity in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). The trial, conducted across 71 international sites from June 2023 to March 2025, involves 175 symptomatic patients experiencing exercise intolerance. Key visuals from the article will be utilised to enhance understanding, while the context highlights...